On the other hand, despite the clear relationship between the resistant phenotype and poor apoptotic responses, we did not find a clear trend regarding expression of key anti-apoptotic factors of the BCL-2 family.
← all excerpts
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models.
1
—
—